Brandi Roberts Insider Trading $SVRA Savara Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brandi Roberts.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brandi Roberts. Brandi Roberts is CFO & SVP Finance in Lineage Cell Therapeutics, Inc. ($BTX) and CFO & SVP, Finance in BIOTIME INC ($BTX) and Chief Financial Officer & SVP in Mast Therapeutics, Inc. ($MSTX) and Vice President, Finance in Mast Therapeutics, Inc. ($MSTX) and SVP & Chief Financial Officer in REVA Medical, Inc. ($RVA).
Brandi Roberts in Savara Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brandi Roberts: Chief Financial Officer & SVP, Vice President, Finance
Holdings: 38,000 shares
Current Value: $5,320
Latest Transaction: Jan 23 2017
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Brandi Roberts in Savara Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BTX, RVA, SVRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2017 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.00 | 889,926 | 0 | 889,926 | |
| Jan 06 2016 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.42 | 572,700 | 240,534 | 572,700 | |
| Jun 12 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.50 | 444,400 | 222,200 | 444,400 | |
| Mar 30 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Buy | P | 0.50 | 18,000 | 8,950 | 38,000 | 20 K to 38 K (+90.00 %) |
| Mar 30 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Buy | P | 0.50 | 20,000 | 10,032 | 20,000 | 0 to 20 K |
| Jan 02 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.58 | 722,800 | 419,224 | 722,800 | |
| Jun 20 2014 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.65 | 336,600 | 218,790 | 336,600 | |
| Jan 03 2014 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.47 | 101,200 | 47,564 | 101,200 | |
| Jun 21 2013 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.50 | 301,250 | 150,625 | 301,250 | |
| Jan 03 2013 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.59 | 75,750 | 44,693 | 75,750 | |
| Dec 09 2011 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Vice President, Fin ... | Option Exercise | A | 0.60 | 140,000 | 84,000 | 140,000 |
Page: 1